Reviewed 2026-06-22
RIDGEVIEW INSTITUTE MONROE
Ownership, control, relationships, and source records for RIDGEVIEW INSTITUTE MONROE.What we can say clearly
RIDGEVIEW INSTITUTE MONROE appears in the source tracker as a venture-backed investment signal. This dossier does not classify that signal as completed private-equity ownership.
- Finding
- Documented investment signal
- Last reviewed
- 2026-06-22
- Evidence
- 6 cited sources
RIDGEVIEW INSTITUTE MONROE appears in the source tracker as a venture-backed investment signal. This dossier does not classify that signal as completed private-equity ownership.
Last verified Jun 2026
Financial assistance help
Bill Reduction Available
Dollar For lists this facility for hospital bill assistance. Eligibility depends on the hospital policy and patient circumstances.Control Map
This leads to this
Evidence limits
Review Note
Why this page is published
Meets the Phase 3 publication standard for its displayed status
Ownership & Control
Detailed records, kept below the answer
Sponsor, operator, CMS legal-owner/control records, and facility are shown as separate evidence layers.
See the full ownership chain
The tracker supplies the sponsor-to-platform attribution; CMS does not independently reproduce every sponsor name.
This signal is not treated as completed hospital ownership.
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 9.9% reported ownership · associated 07/17/2013
5% OR GREATER DIRECT OWNERSHIP INTEREST · 100% reported ownership · associated 07/13/2013
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 13.6% reported ownership · associated 07/17/2013
CORPORATE OFFICER · associated 07/17/2013
CORPORATE DIRECTOR · associated 07/17/2013
W-2 MANAGING EMPLOYEE · associated 07/17/2013
CORPORATE DIRECTOR · associated 08/08/2016
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 9.1% reported ownership · associated 06/17/2016
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 5.6% reported ownership · associated 06/17/2016
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 28.4% reported ownership · associated 07/17/2013
5% OR GREATER INDIRECT OWNERSHIP INTEREST · 5.3% reported ownership · associated 07/17/2013
- CMS owner rows establish enrolled legal ownership or control roles; they do not always name the ultimate financial sponsor.
- Sponsor and portfolio-company labels come from the cited tracker or primary portfolio evidence.
- Investment backing is not classified as completed ownership.
Timeline
Ownership history and events
- venture backing
F-Prime Capital, Eight Roads, George Conrades, Oak HC/FT is reported as an investment backer; this is not treated as a completed ownership claim.
Metrics
Financial and utilization series
| Metric | Period | Value | Method note |
|---|---|---|---|
| net patient revenue | 01/01/2023 to 12/31/2023 | $28,057,291 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| net patient revenue | 01/01/2022 to 12/31/2022 | $23,481,157 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| net patient revenue | 01/01/2021 to 12/31/2021 | $21,061,740 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| operating expense | 01/01/2023 to 12/31/2023 | $23,774,554 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| operating expense | 01/01/2022 to 12/31/2022 | $21,759,066 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| operating expense | 01/01/2021 to 12/31/2021 | $19,643,358 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| net income | 01/01/2023 to 12/31/2023 | $3,921,391 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| net income | 01/01/2022 to 12/31/2022 | $2,414,625 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| net income | 01/01/2021 to 12/31/2021 | $875,489 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total assets | 01/01/2023 to 12/31/2023 | $58,809,733 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total assets | 01/01/2022 to 12/31/2022 | $56,785,233 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total assets | 01/01/2021 to 12/31/2021 | $26,210,180 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total liabilities | 01/01/2023 to 12/31/2023 | $51,146,323 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total liabilities | 01/01/2022 to 12/31/2022 | $54,143,584 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| total liabilities | 01/01/2021 to 12/31/2021 | $33,394,715 | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| fte employees | 01/01/2023 to 12/31/2023 | 193.1 FTE | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| fte employees | 01/01/2022 to 12/31/2022 | 176.4 FTE | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| fte employees | 01/01/2021 to 12/31/2021 | 156.2 FTE | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| beds | 01/01/2023 to 12/31/2023 | 111 beds | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| beds | 01/01/2022 to 12/31/2022 | 111 beds | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| beds | 01/01/2021 to 12/31/2021 | 88 beds | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| patient days | 01/01/2023 to 12/31/2023 | 34,795 days | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| patient days | 01/01/2022 to 12/31/2022 | 31,969 days | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| patient days | 01/01/2021 to 12/31/2021 | 28,897 days | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| discharges | 01/01/2023 to 12/31/2023 | 3,713 discharges | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| discharges | 01/01/2022 to 12/31/2022 | 4,110 discharges | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
| discharges | 01/01/2021 to 12/31/2021 | 3,608 discharges | Hospital Provider Cost Report value. Compare only like fields and compatible fiscal periods; no causal inference is implied. |
Evidence Notes
Contradictions, limitations, and unavailable fields
Open evidence notes
The investment signal does not establish completed private-equity ownership or a pending sale.
Precise acquisition date
Official facility URL
Reported parent system or portfolio company: US HealthVest.
Reported investment sponsor: F-Prime Capital, Eight Roads, George Conrades, Oak HC/FT.
Download
Take the evidence with you
Sources